Cargando…
Synergistic antitumor effect of the combination of a dual cancer-specific oncolytic adenovirus and cisplatin on lung cancer cells
The effect of the combination of a recombinant adenovirus (ATV) expressing a specific apoptin protein and cisplatin on human lung cancer cells (A549 cells) was determined. The inhibitory effects of ATV and cisplatin, ATV alone, or cisplatin alone on the migration and invasion of A549 cells were eval...
Autores principales: | Jin, Jing, Zhu, Yilong, Sun, Fei, Chen, Zhifei, Chen, Shuang, Li, Yiquan, Li, Wenjie, Li, Min, Cui, Chuanxin, Cui, Yingli, Yin, Xunzhi, Li, Shanzhi, Zhao, Jin, Yan, Guo, Li, Xiao, Jin, Ningyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202551/ https://www.ncbi.nlm.nih.gov/pubmed/30405762 http://dx.doi.org/10.3892/ol.2018.9470 |
Ejemplares similares
-
Anti‐tumour effects of a dual cancer‐specific oncolytic adenovirus on Breast Cancer Stem cells
por: Li, Wenjie, et al.
Publicado: (2020) -
Chemovirotherapy of Lung Squamous Cell Carcinoma by Combining Oncolytic Adenovirus With Gemcitabine
por: Liu, Xing, et al.
Publicado: (2020) -
A comparative study of the ability of recombinant oncolytic adenovirus, doxorubicin and tamoxifen to inhibit the proliferation of breast cancer cells
por: Li, Shanzhi, et al.
Publicado: (2022) -
Anti-tumor Synergistic Effect of a Dual Cancer-Specific Recombinant Adenovirus and Paclitaxel on Breast Cancer
por: Wang, Jing, et al.
Publicado: (2020) -
Recombinant Oncolytic Adenovirus Combined with Cyclophosphamide Induces Synergy in the Treatment of Breast Cancer in vitro and in vivo
por: Wang, Jing, et al.
Publicado: (2022)